Showing results (161-170 of 189) with videos related to
Sort By:
Pageof 19
Gastro Hep Advances|November 12, 2024
Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic SamplesWarapen Treekitkarnmongkol, Jianliang Dai, Suyu Liu, et al.Cancer Research Communications|May 6, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal AdenocarcinomaNicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes, et al.ERJ Open Research|May 13, 2026
Asymptomatic tuberculosis detected in health screening predicts favourable outcomeSangjun Park, Hyung Woo Kim, Eung Gu Lee, et al.Thyroid : Official Journal of the American Thyroid Association|July 3, 2025
Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid CancerMaria E Cabanillas, Naifa L Busaidy, G Brandon Gunn, et al.Journal of Korean Medical Science|December 9, 2025
Effect of Isoniazid Resistance on Treatment Outcome Among People With Pulmonary Tuberculosis in KoreaJong Min Lee, Hyung Woo Kim, Eung Gu Lee, et al.Respirology (Carlton, Vic.)|March 28, 2024
Effect of complicated, untreated and uncontrolled diabetes and pre-diabetes on treatment outcome among patients with pulmonary tuberculosisKyung Hoon Kim, Hyung Woo Kim, Yong Hyun Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2026
Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase 2 blinded biomarker validation and panel discovery studyAnn L Oberg, William R Bamlet, Grant Izmirlian, et al.BMC Infectious Diseases|October 8, 2025
Association of overweight with treatment outcomes in pulmonary tuberculosisKyung Hoon Kim, Hyung Woo Kim, Eung Gu Lee, et al.Blood|February 6, 2025
Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myelomaLi Qin, Luz Yurany Moreno Rueda, Upasana Ray, et al.European Urology|April 28, 2026
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 TrialsAlexander D Sherry, Van To, Criselle D'souza, et al.Pageof 19